Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to propofol and remifentanil for anesthesia induction in axillary lymph node dissection
IRCT20230215057420N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in None (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Surgeon satisfaction rate. Started Mar 2024; status: completed.
02
Drugs
magnesium sulfate
Beyond the preview
Go deeper on IRCT20230215057420N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230215057420N2.